John M. Dineen, Director at Merrimack Pharmaceuticals, holds 7.50K shares in Lam Research (Ticker: LRCX), holds 1.83K shares in Cognizant (Ticker: CTSH), holds 0.00 shares in Syneos Health (Ticker: SYNH).
What is the percentage of profitable transactions made by John M. Dineen?
The percentage of profitable transactions made by John M. Dineen is ―.
What is the average return per transaction made by John M. Dineen?
The average return per transaction made by John M. Dineen is ―.
What stocks does John M. Dineen hold?
John M. Dineen holds: MACK, CTSH, SYNH, LRCX stocks.
What was John M. Dineen’s latest transaction?
John M. Dineen latest transaction was an Uninformative Buy of ―.
What was John M. Dineen's most profitable transaction?
John M. Dineen’s most profitable transaction was an Informative Buy of MACK stock on August 13, 2015. The return on the trade was -51.00%.
What is John M. Dineen's role in Merrimack Pharmaceuticals?
John M. Dineen's role in Merrimack Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.